X

Vous n'êtes pas connecté

  - MEDINDIA.NET - Medindia Health News - 27/Jul 07:56

Who Should Consider Preventive Mastectomy for Breast Cancer Risk?

New research suggests preventive mastectomy may be a cost-effective option for women at high risk of breast cancer, prompting a review of current guidelines.

Articles similaires

Who Should Consider Preventive Mastectomy for Breast Cancer Risk?

medindia.net - 26/Jul 20:34

Women at high risk of developing breast cancer should be given greater access to preventive mastectomy, according to a new analysis by researchers...

Sorry! Image not available at this time

Risk-Reducing Mastectomy Cost-Effective With Breast Cancer Risk ≥35 Percent

drugs.com - 28/Jul 15:07

MONDAY, July 28, 2025 -- Undergoing risk-reducing mastectomy (RRM) seems to be cost-effective for women aged 30 to 55 years with a lifetime breast...

Sorry! Image not available at this time

Risk-Reducing Mastectomy Cost-Effective With Breast Cancer Risk ≥35 Percent

drugs.com - 28/Jul 15:07

MONDAY, July 28, 2025 -- Undergoing risk-reducing mastectomy (RRM) seems to be cost-effective for women aged 30 to 55 years with a lifetime breast...

Expanding mastectomy access could prevent more breast cancer cases

news.medical.net - 24/Jul 18:31

More women at higher risk of breast cancer should be offered a mastectomy, according to a new study led by researchers at the London School of Hygiene...

RFK Jr. to oust entire panel behind cancer screening guidelines for being too 'woke': WSJ

rawstory.com - 26/Jul 00:09

The Trump administration is targeting the expert panel that decides which cancer screenings and other preventive services insurance plans are required...

RFK Jr. to oust entire panel behind cancer screening guidelines for being too 'woke': WSJ

rawstory.com - 26/Jul 00:09

The Trump administration is targeting the expert panel that decides which cancer screenings and other preventive services insurance plans are required...

NICE recommends ribociclib for eligible HR+/HER2- early breast cancer patients at high risk of recurrence

oncologynews.com.au - 27/Jul 21:42

Novartis Pharmaceuticals UK announced that the National Institute for Health and Care Excellence (NICE) has recommended ribociclib, within its...

NICE recommends ribociclib for eligible HR+/HER2- early breast cancer patients at high risk of recurrence

oncologynews.com.au - 27/Jul 21:42

Novartis Pharmaceuticals UK announced that the National Institute for Health and Care Excellence (NICE) has recommended ribociclib, within its...

Sorry! Image not available at this time

Are you drinking heavily? You may be at greater risk of liver disease

factpatrol.com - 25/Jul 08:02

The rate of serious liver disease among heavy drinkers has more than doubled over the last 20 years as the demographics around who is consuming more...

Sorry! Image not available at this time

Are you drinking heavily? You may be at greater risk of liver disease

factpatrol.com - 25/Jul 08:02

The rate of serious liver disease among heavy drinkers has more than doubled over the last 20 years as the demographics around who is consuming more...